Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Back to Industry News
Medtech

UnitedHealth Investors Confident in Hemsley's Return Amidst Turnaround Efforts

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Reuters, Reuters
TL;DR

Stephen Hemsley is back as UnitedHealth Group's CEO after the company missed earnings projections for the first time since 2008. His three-year contract, potential $60 million in stock, and $25 million personal investment, alongside plans like a potential Medicare Advantage exit, have revitalized investor confidence, which includes strong support from Berkshire Hathaway and firms like Smead Capital Management.

Key takeaways

  • Investors are optimistic that Stephen Hemsley's return as CEO of UnitedHealth Group will revitalize the company after a difficult year that saw it miss earnings projections for the first time since 2008
  • Hemsley, who previously served as CEO from 2006 to 2017, enjoys strong investor support, including from Berkshire Hathaway
  • His commitment is underscored by a three-year contract potentially worth $60 million in stock and his personal investment of approximately $25 million in UnitedHealth Group shares
Investors are optimistic that Stephen Hemsley's return as CEO of UnitedHealth Group will revitalize the company after a difficult year that saw it miss earnings projections for the first time since 2008. Hemsley, who previously served as CEO from 2006 to 2017, enjoys strong investor support, including from Berkshire Hathaway. His commitment is underscored by a three-year contract potentially worth $60 million in stock and his personal investment of approximately $25 million in UnitedHealth Group shares. This, combined with strategic plans that include a potential Medicare Advantage market exit, is bolstering investor confidence. Smead Capital Management, which holds nearly 300,000 shares, is among those expressing renewed optimism.

Related Topics

UnitedHealth GroupStephen HemsleyCEOinvestorsturnaroundOptumBerkshire Hathaway

Verified mention available

Free to claim

Is this your company?

Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.

Set up alerts Takes under 1 minute • Verified manually

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original